Table 1

NOS2, COX2, VEGF, and MDV status in relation to patients’ demographic data, cancer histopathology, and clinical staging

No.NOS2 (%)COX2 (%)VEGF (%)MVD/m2
All10651 (48)51 (48)61 (58)76.3
Male6230 (48)27 (44)36 (58)74.6
Female4421 (48)24 (55)25 (57)78.7
Smoking history
Smokers10249 (47)50 (48)55 (54)76.5
Nonsmokers41 (25)3 (75)2 (50)71.0
Histology
ADC5528 (49)29 (53)34 (56)79.0
SCC297 (27)14 (48)13 (45)64.0
LCC2216 (73)11 (50)14 (64)89.0
Tumor size
T12417 (71)11 (46)18 (75)78.3
T24330 (70)22 (51)28 (65)82.1
T33921 (54)24 (62)25 (64)67.5
Lymph node status
N05636 (64)27 (48)35 (63)72.4
N13019 (63)19 (63)21 (70)76.9
N21812 (67)11 (61)13 (72)83.0
Clinical stage
I5235 (67)29 (56)35 (67)72.1
II1911 (58)8 (42)13 (68)80.4
III2617 (65)16 (62)16 (62)79.2
IV85 (63)6 (75)7 (88)86.9